Tags : Insight

Viewpoints

ViewPoints Interview: Codiak BioSciences’ Douglas E. Williams Shares Insight on

In an interview with PharmaShots, Douglas E. Williams, Ph.D., President and Chief Executive Officer of Codiak BioSciences shares insights on the potential of engineered exosomes and the data presented at SITC 2020. Shots: Codiak demonstrated the potential of engineered exosomes –  extracellular vesicles that act like the body’s FedEx delivery trucks to carry messengers between […]Read More

Viewpoints

ViewPoints Interview: Fluxergy’s Tej Patel Shares Insight on Multimodal Diagnostic

In an interview with PharmaShots, Tej Patel, CEO of Fluxergy shared his views on Fluxergy’s CE Marking and how it will democratize healthcare while creating better clinical outcomes. Shots: Fluxergy’s One-hour COVID-19 test requires less than 2-3 minutes of hands-on time and provides lab-quality RT-PCR test results within an hour. The Fluxergy analyzer is a […]Read More

Viewpoints

ViewPoints Interview: Eli Lilly’s Marie Schiller Shares Insight on the

In an interview with PharmaShots, Marie Schiller Vice President of Product Development for Connected Care and Insulins at Lilly shared her views on its collaboration with Welldoc to integrate Welldoc’s insulin management technology into Lilly’s connected insulin solutions. Shots: Lilly and Welldoc are teaming up to create a new version of Welldoc’s BlueStar app which will be […]Read More

Viewpoints

ViewPoints Interview: Cardiff Oncology’s Mark Erlander Shares Insight on the

In an interview with PharmaShots, Mark Erlander, CEO of Cardiff Oncology shared his views on the data presented at the ASCO-GI Conference, P-Ib results of Onvansertib, what these results meant for the patients with this aggressive type of mCRC, and the company’s other ongoing programs for Onvansertib, including metastatic castration-resistant prostate cancer and AML Shots: […]Read More